MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 33 filers reported holding MYOVANT SCIENCES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,040,000 | -90.6% | 800,000 | -80.6% | 0.20% | -89.1% |
| Q4 2019 | $64,038,000 | +162.3% | 4,126,131 | -12.1% | 1.80% | +123.5% |
| Q3 2019 | $24,414,000 | -37.1% | 4,694,917 | +9.6% | 0.81% | -31.6% |
| Q2 2019 | $38,785,000 | -34.2% | 4,285,612 | +73.6% | 1.18% | -41.9% |
| Q1 2019 | $58,936,000 | +62.9% | 2,469,021 | +12.0% | 2.03% | +26.6% |
| Q4 2018 | $36,179,000 | -35.6% | 2,204,708 | +4.2% | 1.60% | -22.3% |
| Q3 2018 | $56,153,000 | +53.3% | 2,115,000 | +32.1% | 2.06% | +35.7% |
| Q2 2018 | $36,630,000 | +200.3% | 1,601,661 | +179.3% | 1.52% | +166.2% |
| Q1 2018 | $12,199,000 | +74.8% | 573,553 | +3.9% | 0.57% | +56.9% |
| Q4 2017 | $6,979,000 | -18.0% | 552,100 | +0.4% | 0.36% | -24.5% |
| Q3 2017 | $8,509,000 | +32.2% | 550,000 | 0.0% | 0.48% | +20.2% |
| Q2 2017 | $6,435,000 | +85.8% | 550,000 | +86.4% | 0.40% | +75.1% |
| Q1 2017 | $3,463,000 | – | 295,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |